Engineered Aptamers for Enhanced COVID-19 Theranostics.

Caleb AcquahJaison JeevanandamKei Xian TanMichael Kobina Danquah

Published in: Cellular and molecular bioengineering (2021)

There is an urgent need to develop safe innovative biomedical technologies to mitigate the dire impact of COVID-19 on public health worldwide. Research advances into aptameric systems bode well with the fact that they can be engineered for the development of effective and affordable diagnostics, therapeutics and prophylactic vaccines for SARS-CoV-2 and other infectious pathogens.

Keyphrases

sars cov
public health
coronavirus disease
respiratory syndrome coronavirus
small molecule
gram negative
nucleic acid